Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with...

ver descrição completa

Detalhes bibliográficos
Autores: Vigón, Lorena, Vázquez-Morón, Sonia|||0000-0002-0977-741X, Berenguer, Juan|||0000-0001-8541-8200, González-García, Juan|||0000-0002-3652-002X, Jiménez-Sousa, Ma Ángeles, Guardiola Tey, Jose Maria|||0000-0001-5537-2600, Crespo Casal, Manuel|||0000-0001-9016-0515, de los Santos Gil, Ignacio|||0000-0001-7073-5211, Von Wichmann, Miguel Ángel, Carrero, Ana, Yélamos, María Belén, Gómez, Julián, Resino, Salvador|||0000-0001-8783-0450, Martínez, Isidoro|||0000-0002-9949-9264, Miralles, Pilar, López, J.C., Parras, F., Padilla Ortega, Belén, Aldámiz-Echevarría, T., Tejerina, F., Diez, Cristina, Pérez-Latorre, L., Fanciulli, Chiara|||0000-0003-2175-9027, Gutiérrez, I., Ramírez, Manuel|||0000-0003-0332-6973, Carretero, S., Bellón, José-María|||0000-0002-8492-1565, Bermejo, Javier|||0000-0002-5241-2758, Hontañón, V., Arribas, Jose|||0000-0002-7410-9450, Montes, M.L., Bernardino, I., Pascual, J.F., Zamora, Francisco, Peña, J.M., Arnalich, F., Díaz, M., Domingo Pedrol, Pedro|||0000-0003-1138-5770, Sanz, Jaime|||0000-0001-6934-4619, Bustinduy, M.J., Iribarren, José Antonio, Rodríguez-Arrondo, F., Eynde, E.Van den, Pérez, M., Ribera, E., Casado, José Luis|||0000-0002-7639-8591, Dronda, Fernando|||0000-0002-0443-5816, Moreno, A., Pérez Elías, Mª Jesus|||0000-0001-5700-5257, Sanfrutos, M.A., Moreno, S., Quereda, Carmen, Arranz, A., Casas Díaz, Encarna|||0000-0002-5901-6555, Miguel, J.de, Schroeder, S., Vergas, J., Téllez, M.J., Vinuesa, D., Muñoz, Lourdes, Hernández Quero, José, Ferrer, A., Galindo, María José, Ortiz, L., Ortega, Emilio|||0000-0002-2217-8905, Montero, M., Blanes, M., Cuellar, S., Lacruz, José, Salavert, Miguel|||0000-0002-8571-2124, López-Aldeguer, J., Pérez González, Gustavo|||0000-0001-9112-9042, Gaspar, G., Yllescas, M., Crespo, P., Aznar, E., Esteban, H.
Formato: artículo
Fecha de publicación:2019
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:286570
Acesso em linha:https://ddd.uab.cat/record/286570
https://dx.doi.org/urn:doi:10.1038/s41598-019-48592-5
Access Level:acceso abierto
Palavra-chave:Antibodies
Hepatitis C
Hepatitis C virus
id ES_cd3ce5a01fd3e7c8b8b47acf952f4a84
oai_identifier_str oai:ddd.uab.cat:286570
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
title Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
spellingShingle Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Vigón, Lorena
Antibodies
Hepatitis C
Hepatitis C virus
title_short Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
title_full Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
title_fullStr Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
title_full_unstemmed Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
title_sort Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
dc.creator.none.fl_str_mv Vigón, Lorena
Vázquez-Morón, Sonia|||0000-0002-0977-741X
Berenguer, Juan|||0000-0001-8541-8200
González-García, Juan|||0000-0002-3652-002X
Jiménez-Sousa, Ma Ángeles
Guardiola Tey, Jose Maria|||0000-0001-5537-2600
Crespo Casal, Manuel|||0000-0001-9016-0515
de los Santos Gil, Ignacio|||0000-0001-7073-5211
Von Wichmann, Miguel Ángel
Carrero, Ana
Yélamos, María Belén
Gómez, Julián
Resino, Salvador|||0000-0001-8783-0450
Martínez, Isidoro|||0000-0002-9949-9264
Miralles, Pilar
López, J.C.
Parras, F.
Padilla Ortega, Belén
Aldámiz-Echevarría, T.
Tejerina, F.
Diez, Cristina
Pérez-Latorre, L.
Fanciulli, Chiara|||0000-0003-2175-9027
Gutiérrez, I.
Ramírez, Manuel|||0000-0003-0332-6973
Carretero, S.
Bellón, José-María|||0000-0002-8492-1565
Bermejo, Javier|||0000-0002-5241-2758
Hontañón, V.
Arribas, Jose|||0000-0002-7410-9450
Montes, M.L.
Bernardino, I.
Pascual, J.F.
Zamora, Francisco
Peña, J.M.
Arnalich, F.
Díaz, M.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Sanz, Jaime|||0000-0001-6934-4619
Bustinduy, M.J.
Iribarren, José Antonio
Rodríguez-Arrondo, F.
Eynde, E.Van den
Pérez, M.
Ribera, E.
Casado, José Luis|||0000-0002-7639-8591
Dronda, Fernando|||0000-0002-0443-5816
Moreno, A.
Pérez Elías, Mª Jesus|||0000-0001-5700-5257
Sanfrutos, M.A.
Moreno, S.
Quereda, Carmen
Arranz, A.
Casas Díaz, Encarna|||0000-0002-5901-6555
Miguel, J.de
Schroeder, S.
Vergas, J.
Téllez, M.J.
Vinuesa, D.
Muñoz, Lourdes
Hernández Quero, José
Ferrer, A.
Galindo, María José
Ortiz, L.
Ortega, Emilio|||0000-0002-2217-8905
Montero, M.
Blanes, M.
Cuellar, S.
Lacruz, José
Salavert, Miguel|||0000-0002-8571-2124
López-Aldeguer, J.
Pérez González, Gustavo|||0000-0001-9112-9042
Gaspar, G.
Yllescas, M.
Crespo, P.
Aznar, E.
Esteban, H.
author Vigón, Lorena
author_facet Vigón, Lorena
Vázquez-Morón, Sonia|||0000-0002-0977-741X
Berenguer, Juan|||0000-0001-8541-8200
González-García, Juan|||0000-0002-3652-002X
Jiménez-Sousa, Ma Ángeles
Guardiola Tey, Jose Maria|||0000-0001-5537-2600
Crespo Casal, Manuel|||0000-0001-9016-0515
de los Santos Gil, Ignacio|||0000-0001-7073-5211
Von Wichmann, Miguel Ángel
Carrero, Ana
Yélamos, María Belén
Gómez, Julián
Resino, Salvador|||0000-0001-8783-0450
Martínez, Isidoro|||0000-0002-9949-9264
Miralles, Pilar
López, J.C.
Parras, F.
Padilla Ortega, Belén
Aldámiz-Echevarría, T.
Tejerina, F.
Diez, Cristina
Pérez-Latorre, L.
Fanciulli, Chiara|||0000-0003-2175-9027
Gutiérrez, I.
Ramírez, Manuel|||0000-0003-0332-6973
Carretero, S.
Bellón, José-María|||0000-0002-8492-1565
Bermejo, Javier|||0000-0002-5241-2758
Hontañón, V.
Arribas, Jose|||0000-0002-7410-9450
Montes, M.L.
Bernardino, I.
Pascual, J.F.
Zamora, Francisco
Peña, J.M.
Arnalich, F.
Díaz, M.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Sanz, Jaime|||0000-0001-6934-4619
Bustinduy, M.J.
Iribarren, José Antonio
Rodríguez-Arrondo, F.
Eynde, E.Van den
Pérez, M.
Ribera, E.
Casado, José Luis|||0000-0002-7639-8591
Dronda, Fernando|||0000-0002-0443-5816
Moreno, A.
Pérez Elías, Mª Jesus|||0000-0001-5700-5257
Sanfrutos, M.A.
Moreno, S.
Quereda, Carmen
Arranz, A.
Casas Díaz, Encarna|||0000-0002-5901-6555
Miguel, J.de
Schroeder, S.
Vergas, J.
Téllez, M.J.
Vinuesa, D.
Muñoz, Lourdes
Hernández Quero, José
Ferrer, A.
Galindo, María José
Ortiz, L.
Ortega, Emilio|||0000-0002-2217-8905
Montero, M.
Blanes, M.
Cuellar, S.
Lacruz, José
Salavert, Miguel|||0000-0002-8571-2124
López-Aldeguer, J.
Pérez González, Gustavo|||0000-0001-9112-9042
Gaspar, G.
Yllescas, M.
Crespo, P.
Aznar, E.
Esteban, H.
author_role author
author2 Vázquez-Morón, Sonia|||0000-0002-0977-741X
Berenguer, Juan|||0000-0001-8541-8200
González-García, Juan|||0000-0002-3652-002X
Jiménez-Sousa, Ma Ángeles
Guardiola Tey, Jose Maria|||0000-0001-5537-2600
Crespo Casal, Manuel|||0000-0001-9016-0515
de los Santos Gil, Ignacio|||0000-0001-7073-5211
Von Wichmann, Miguel Ángel
Carrero, Ana
Yélamos, María Belén
Gómez, Julián
Resino, Salvador|||0000-0001-8783-0450
Martínez, Isidoro|||0000-0002-9949-9264
Miralles, Pilar
López, J.C.
Parras, F.
Padilla Ortega, Belén
Aldámiz-Echevarría, T.
Tejerina, F.
Diez, Cristina
Pérez-Latorre, L.
Fanciulli, Chiara|||0000-0003-2175-9027
Gutiérrez, I.
Ramírez, Manuel|||0000-0003-0332-6973
Carretero, S.
Bellón, José-María|||0000-0002-8492-1565
Bermejo, Javier|||0000-0002-5241-2758
Hontañón, V.
Arribas, Jose|||0000-0002-7410-9450
Montes, M.L.
Bernardino, I.
Pascual, J.F.
Zamora, Francisco
Peña, J.M.
Arnalich, F.
Díaz, M.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Sanz, Jaime|||0000-0001-6934-4619
Bustinduy, M.J.
Iribarren, José Antonio
Rodríguez-Arrondo, F.
Eynde, E.Van den
Pérez, M.
Ribera, E.
Casado, José Luis|||0000-0002-7639-8591
Dronda, Fernando|||0000-0002-0443-5816
Moreno, A.
Pérez Elías, Mª Jesus|||0000-0001-5700-5257
Sanfrutos, M.A.
Moreno, S.
Quereda, Carmen
Arranz, A.
Casas Díaz, Encarna|||0000-0002-5901-6555
Miguel, J.de
Schroeder, S.
Vergas, J.
Téllez, M.J.
Vinuesa, D.
Muñoz, Lourdes
Hernández Quero, José
Ferrer, A.
Galindo, María José
Ortiz, L.
Ortega, Emilio|||0000-0002-2217-8905
Montero, M.
Blanes, M.
Cuellar, S.
Lacruz, José
Salavert, Miguel|||0000-0002-8571-2124
López-Aldeguer, J.
Pérez González, Gustavo|||0000-0001-9112-9042
Gaspar, G.
Yllescas, M.
Crespo, P.
Aznar, E.
Esteban, H.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Antibodies
Hepatitis C
Hepatitis C virus
topic Antibodies
Hepatitis C
Hepatitis C virus
description The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to perform neutralization assays against five JFH1-based HCV recombinant viruses coding for E1 and E2 from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those titers declined soon after SVR.
publishDate 2019
dc.date.none.fl_str_mv 2
2019-01-01
2019
2019-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/286570
https://dx.doi.org/urn:doi:10.1038/s41598-019-48592-5
url https://ddd.uab.cat/record/286570
https://dx.doi.org/urn:doi:10.1038/s41598-019-48592-5
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD12/0017/0037
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI14/01094
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17/00657
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17/00903
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0018
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0017
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 INT15/00079
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 INT16/00100
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419791919349760
spelling Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRVigón, LorenaVázquez-Morón, Sonia|||0000-0002-0977-741XBerenguer, Juan|||0000-0001-8541-8200González-García, Juan|||0000-0002-3652-002XJiménez-Sousa, Ma ÁngelesGuardiola Tey, Jose Maria|||0000-0001-5537-2600Crespo Casal, Manuel|||0000-0001-9016-0515de los Santos Gil, Ignacio|||0000-0001-7073-5211Von Wichmann, Miguel ÁngelCarrero, AnaYélamos, María BelénGómez, JuliánResino, Salvador|||0000-0001-8783-0450Martínez, Isidoro|||0000-0002-9949-9264Miralles, PilarLópez, J.C.Parras, F.Padilla Ortega, BelénAldámiz-Echevarría, T.Tejerina, F.Diez, CristinaPérez-Latorre, L.Fanciulli, Chiara|||0000-0003-2175-9027Gutiérrez, I.Ramírez, Manuel|||0000-0003-0332-6973Carretero, S.Bellón, José-María|||0000-0002-8492-1565Bermejo, Javier|||0000-0002-5241-2758Hontañón, V.Arribas, Jose|||0000-0002-7410-9450Montes, M.L.Bernardino, I.Pascual, J.F.Zamora, FranciscoPeña, J.M.Arnalich, F.Díaz, M.Domingo Pedrol, Pedro|||0000-0003-1138-5770Sanz, Jaime|||0000-0001-6934-4619Bustinduy, M.J.Iribarren, José AntonioRodríguez-Arrondo, F.Eynde, E.Van denPérez, M.Ribera, E.Casado, José Luis|||0000-0002-7639-8591Dronda, Fernando|||0000-0002-0443-5816Moreno, A.Pérez Elías, Mª Jesus|||0000-0001-5700-5257Sanfrutos, M.A.Moreno, S.Quereda, CarmenArranz, A.Casas Díaz, Encarna|||0000-0002-5901-6555Miguel, J.deSchroeder, S.Vergas, J.Téllez, M.J.Vinuesa, D.Muñoz, LourdesHernández Quero, JoséFerrer, A.Galindo, María JoséOrtiz, L.Ortega, Emilio|||0000-0002-2217-8905Montero, M.Blanes, M.Cuellar, S.Lacruz, JoséSalavert, Miguel|||0000-0002-8571-2124López-Aldeguer, J.Pérez González, Gustavo|||0000-0001-9112-9042Gaspar, G.Yllescas, M.Crespo, P.Aznar, E.Esteban, H.AntibodiesHepatitis CHepatitis C virusThe main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to perform neutralization assays against five JFH1-based HCV recombinant viruses coding for E1 and E2 from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those titers declined soon after SVR.Universitat Autònoma de Barcelona 22019-01-0120192019-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/286570https://dx.doi.org/urn:doi:10.1038/s41598-019-48592-5reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD12/0017/0037Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI14/01094Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17/00657Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI17/00903Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0018Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0017Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 INT15/00079Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 INT16/00100open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2865702026-06-06T12:50:31Z
score 15,300724